Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANS Genesis RC

This article was originally published in The Gray Sheet

Executive Summary

Premarket development of "smaller" and "more powerful" second-generation rechargeable implantable pulse generators has begun following Advanced Neuromodulation Systems' recent PMA supplement approval of first-generation rechargeable Genesis RC and RC Dual neurostim systems for pain, the firm says. ANS is "building inventory" for a test launch. The firm previously offered non-rechargeable versions. Boston Scientific unit Advanced Bionics' Precision became the first FDA-approved rechargeable spinal cord stimulator in April...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT021326

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel